Clinical Trial Update: Niraparib Versus Niraparib-bevacizumab Combination in Women With Platinum-sensitive Epithelial Ovarian Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial comparing niraparib alone to niraparib with bevacizumab in platinum-sensitive epithelial ovarian cancer; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Niraparib (Niraparib)

Snippet

Sponsor: Nordic Society of Gynaecological Oncology - Clinical Trials Unit | Conditions: Ovarian Cancer | Phase 1, Phase 2 | Status: COMPLETED